*bicker* wrote in message ...
A 3 Aug 2004 14:44:42 GMT, Ignoramus7404
escribió:
I am thinking of joining, and am curious if anyone else here has. Is
it a hassle? Will I be bothered all the time by researchers or some
other things, or not?

No hassle at all. We receive surveys every so often, and
follow-ups if there is anything that didn't go through
directly. In two years we've gotten only three press
inquiries (one of which led to our appearance on Good
Morning America), and of those, only one wasn't well-vetted
IMHO. (It was a stringer, who really was a college student
doing a paper, rather than contacting the NWCR as a member
of the press on assignment as originally claimed.)

The National Weight Control Registry is run by James O. Hill and Rena
R. Wing.

Here is some info about these people and others that have been
connected to this project and some of its studies.

***************************
James O. Hill, Ph.D., Professor of Pediatrics and Director, Center for
Human Nutrition at the University of Colorado Health Sciences Center,
Denver, CO. Research support from Amgen, Hoffman-LaRoche, Procter &
Gamble, and Knoll Pharmaceuticals; has received consultant fees from
Knoll, Roche Laboratories, International Life Sciences Institute, and
Procter & Gamble and is a consultant to the Duke Diet and Fitness
Center. (Newark Star-Ledger, 2/17/97). President, North American
Association for the Study of Obesity. (USA Today, 9/1/98) Lead author
of a study on olestra supported by a grant from Procter & Gamble. (Am.
J. Clin. Nutr. 1998;67:1178-85) Co-wrote (with Barbara Rolls) a 1998
report for ILSI on "Carbohydrates and Weight Management." Participated
in a 3/25/99 panel assembled by the Sugar Association to inform New
York magazine editors about obesity, calories, and activity. (Sugar
Association's 1999 annual report,
http://www.foodingredientsonline.com; accessed 03/30/99) Research on
the effects of covert substitution of olestra for conventional fat on
spontaneous food intake supported by Procter & Gamble. (Am. J. Clin.
Nutr. 1998;67:1178-85) Research on the role of carbohydrates in weight
management was supported by the Sugar Association. (Letter from Sugar
Association to USDA; on file with CSPI; 4/16/99) Research on using
Orlistat for weight maintenance funded by Hoffmann-La Roche. (Am. J.
Clin. Nutr. 1999;69:1108-16) Member of the Foodfit.com advisory board.
(http://www.foodfit.com/about/advisoryBoard.asp; accessed 11/11/00)
Research on weight management supported in part by Abbott
Laboratories. (J. Amer. Coll. Nutr. 2001;20:26-31) Member of the
McDonald's Corporation Global Advisory Council on Healthy Lifestyles;
formed to "help guide the company on activities that address the need
for balanced, healthy lifestyles."
(http://www.mcdonalds.com/corporate/p...003/05212003/;
accessed 6/23/03) Receives consulting fees from HealtheTech, Johnson &
Johnson, Procter & Gamble, and Coca-Cola. Receives speakers fees from
Abbott Laboratories, Roche Laboratories, and Kraft Foods. Receives
research funding from M&M Mars. (N. Engl. J. Med. 2003:348;2082-2090)
Member of the expert advisory board for the American Council for
Fitness and Nutrition. (http://www.acfn.org/about/advisory.html;
accessed 10/31/03)

Rena R. Wing, Ph.D., U. of Pittsburgh School of Medicine. Consultant
to and received research support from Lilly Pharmaceuticals, is on
Weight Watchers Advisory Board; has received research support from
Ross Laboratories and ILSI. (Newark Star-Ledger, 2/17/97 notes Eli
Lilly, WW)

Holly R. Wyatt, M.D., Assistant Professor of Medicine, University of
Colorado Health Sciences Center, Denver. Receives consulting fees from
Ortho-McNeil, USANA, and GlaxoSmithKline. Receives speaker fees from
Roche Laboratories, Abbott Laboratories, Slim-Fast, and Ortho-McNeil.
(N. Engl. J. Med. 2003;348:2082-90)

Helen M. Seagle, Co-authored a study on olestra and obesity supported
by a grant from Procter & Gamble. (Am. J. Clin. Nutr. 1998;67:1178-85)
************************************

I would have to say that the National Weight Control Registry is
somewhat suspect in its operation and in its reason for being. There
appears to be a specific agenda in place for the kind of data and the
use of the data being collected.

TC